New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
The International Harmonization Project developed recommendations for the use of positron emission tomography (PET) in managing patients who have lymphoma. It provided guidance as to the interpretation of fluorodeoxyglucose (FDG) PET and generated response definitions, incorporating metabolic imaging with the goal of improving interpretation of response and comparability among studies, leading to accelerated new agent development, more rapid availability of more effective therapies, and the enhancement of outcome for patients with lymphoma.
Cheson
Bruce D
BD
Georgetown University Hospital, Lombardi Comprehensive Cancer Center, 3800 Reservoir Road Northwest, Washington, DC 20007, USA. bdc4@georgetown.edu
D002986:Clinical Trials as Topic; D018450:Disease Progression; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18